ATE86119T1 - Lebendvaccine fuer ansteckungskrankheiten von kueken. - Google Patents

Lebendvaccine fuer ansteckungskrankheiten von kueken.

Info

Publication number
ATE86119T1
ATE86119T1 AT87110291T AT87110291T ATE86119T1 AT E86119 T1 ATE86119 T1 AT E86119T1 AT 87110291 T AT87110291 T AT 87110291T AT 87110291 T AT87110291 T AT 87110291T AT E86119 T1 ATE86119 T1 AT E86119T1
Authority
AT
Austria
Prior art keywords
live vaccine
infectious diseases
infectious laryngotracheitis
live
chick
Prior art date
Application number
AT87110291T
Other languages
German (de)
English (en)
Inventor
Takashi Honda
Akira Taneno
Takuma Hanaki
Masanobu Eto
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE86119T1 publication Critical patent/ATE86119T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
AT87110291T 1986-07-17 1987-07-16 Lebendvaccine fuer ansteckungskrankheiten von kueken. ATE86119T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61170188A JPS6327437A (ja) 1986-07-17 1986-07-17 鶏伝染病生ワクチン

Publications (1)

Publication Number Publication Date
ATE86119T1 true ATE86119T1 (de) 1993-03-15

Family

ID=15900313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87110291T ATE86119T1 (de) 1986-07-17 1987-07-16 Lebendvaccine fuer ansteckungskrankheiten von kueken.

Country Status (9)

Country Link
US (1) US4980162A (enExample)
EP (1) EP0253389B1 (enExample)
JP (1) JPS6327437A (enExample)
KR (1) KR940010022B1 (enExample)
AT (1) ATE86119T1 (enExample)
CA (1) CA1292689C (enExample)
DE (1) DE3784397T2 (enExample)
ES (1) ES2053477T3 (enExample)
GR (1) GR3007856T3 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436005A (en) * 1989-08-01 1995-07-25 Arthur Webster Pty. Ltd. Low virulence infectiouns laryngotracheitis (ILT) virus for vaccinating birds
AU647404B2 (en) * 1989-08-01 1994-03-24 Pfizer Australia Pty Ltd Low virulence laryngotracheitis (ILT) virus for vaccinating birds
US5279965A (en) * 1991-04-05 1994-01-18 Keeler Jr Calvin L Recombinant infectious laryngotracheitis virus
US5443831A (en) * 1991-10-29 1995-08-22 University Of Delaware Gene encoding glycoprotein B of Infectious Laryngotracheitis Virus
US5443982A (en) * 1993-07-13 1995-08-22 Solvay Animal Health, Inc. Methods for the cultivation of infectious laryngotracheitis virus
JPH09505726A (ja) * 1993-09-24 1997-06-10 シントロ・コーポレーション 組換え感染性喉頭気管炎ウイルス及びそれらの使用
US6984728B2 (en) * 1993-09-24 2006-01-10 Schering Corporation Recombinant infectious laryngotracheitis virus and uses thereof
WO1995018860A1 (en) * 1994-01-11 1995-07-13 Cornell Research Foundation, Inc. Control of marek's disease by the inhibition of latency and tumor cell development
EP3727431A1 (en) * 2017-12-20 2020-10-28 Intervet International B.V. Improved diluent for cell-associated alphaherpesvirus vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3331736A (en) * 1963-02-11 1967-07-18 Schering Corp Modified laryngotracheitis vaccine
US3444293A (en) * 1964-08-24 1969-05-13 Vineland Poultry Lab Multifunctional laryngotracheitis vaccine and method of making the same
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US3981771A (en) * 1973-07-19 1976-09-21 Martin Sevoian Marek's disease vaccine
ZA743771B (en) * 1973-07-19 1975-07-30 M Sevoian Vaccine and preparation thereof
JPS57167925A (en) * 1981-04-08 1982-10-16 Handai Biseibutsubiyou Kenkyukai Preparation of mixed vaccine for domestic fowl

Also Published As

Publication number Publication date
DE3784397T2 (de) 1993-06-17
CA1292689C (en) 1991-12-03
JPH0317807B2 (enExample) 1991-03-11
JPS6327437A (ja) 1988-02-05
DE3784397D1 (de) 1993-04-08
US4980162A (en) 1990-12-25
GR3007856T3 (enExample) 1993-08-31
EP0253389A1 (en) 1988-01-20
ES2053477T3 (es) 1994-08-01
EP0253389B1 (en) 1993-03-03
KR880001808A (ko) 1988-04-27
KR940010022B1 (ko) 1994-10-20

Similar Documents

Publication Publication Date Title
ATE60799T1 (de) Virus-impfstoff.
HU9401056D0 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
DE68920610D1 (de) Rekombinantes Virus der Marekschen Krankheit und Vakzin.
NO882500L (no) Hunde-coronavirus-vaksine.
ATE86119T1 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
LU91303I2 (fr) Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP
ES373631A1 (es) Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret.
DE3751772D1 (de) Impfstoff zur behandlung von hsv
ES2091083T3 (es) Vacuna y ensayo de diagnostico para el virus del colera porcino.
ES2061850T3 (es) Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna.
MX9102757A (es) Vacuna de virus de enfermedad de marek sin celulas.
NZ228232A (en) Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry
EA200100720A1 (ru) Вирусная вакцина на основе делеционного вируса герпеса крупного рогатого скота типа 1 (bhv-1)
EP0496787A4 (en) Novel infectious bursal disease virus
DK506979A (da) Vaccine mod infektioes katte-peritonitis og fremgangsmaade til dens fremstilling
DK306379A (da) Herpesvirusvaccine
DK165359C (da) Vaccine mod smitsom bronkitis hos daggamle kyllinger, samt virusstamme indeholdt i vaccinen
ATE62134T1 (de) Biologische zubereitungen.
Honda et al. Live vaccine for contagious diseases of chickens.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0253389

Country of ref document: EP

REN Ceased due to non-payment of the annual fee